Nabi Biopharmaceuticals - Earnings Estimates

INVESTORS

Advanced
Fundamentals

Investor FAQ

Information
Requests

Corporate
Governance

Earnings Estimates

First Call Mean Estimates

Fiscal Year Ending: Dec - Last Changed: 03/14/12

YR Ending	Q1 Mar	Q2 Jun	Q3 Sep	Q4 Dec	Fisc Yr Annual	Num Brokers	Cal Yr Annual	Num Brokers
2015						0	0.09	1
2014						0	0.01	1
2013						0	-0.08	1
2012						0	-0.37	1
2011	0.05A	-0.11A	-0.07A	A	-0.18	1	-0.18	0
2010	0.11A	-0.08A	0.12A	-0.15A	0.02	2	0.02	2
2009	-0.14A	-0.11A	-0.14A	0.02A	-0.37	2	-0.37	2
2008	-0.12A	-0.01A	-0.03A	-0.05A	-0.20	2	-0.20	2
2007	-0.17A	-0.09A	-0.26A	-0.07A	-0.65	1	-0.65	1
2006	-0.30A	-0.24A	-0.27A	-0.13A	-0.94	2	-0.94	2
2005	-0.27A	-0.35A	-0.27A	-1.25A	-2.15	5	-2.15	5
1999	-0.01A	0.03A	0.04A	0.04A	0.09	0	0.09	0
1998	-0.06A	-0.01A	-0.11A	-0.02A	-0.20	0	-0.20	0

Mean Recommendation: 3

Mean Future 5 Year Growth Rate: N/A

Disclaimer: Mean Earnings Estimates are calculated by First Call based on the earnings projections made by the analysts who cover Nabi Biopharmaceuticals. Please note that any opinions, estimates or forecasts regarding Nabi Biopharmaceuticals performance made by these analysts (and therefore the Mean estimate numbers) are theirs alone and do not represent opinions, forecasts or predictions of Nabi Biopharmaceuticals or its management. Nabi Biopharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

^ Top